Not Yet Recruiting
Evaluation of the Efficacy and Safety of Tirzepatide, a Dual GLP-1/GIP Agonist, on Functional Capacity in Reduced Ejection Fraction Heart Failure Patients With Obesity
NCT07738276
- Conditions
- Body Weight, Body Weight Changes, Cardiovascular Diseases, +14 more
- Locations
-
Not specified